Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

During the Trading Day
48.90 -0.75 / -1.51%
As of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
49.05 +0.1523 / +0.31%
 
Volume: 3.4K

Today’s Trading

Previous close49.65
Today’s open49.65
Day’s range48.62 - 49.70
Volume1,982,127
Average volume (3 months)1,501,427
Market cap$99.6B
Dividend yield1.55%
Data as of 4:02pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.40%
Revenue growth (last year)+5.60%
P/E ratio3.8
Price/Sales7.07
Price/Book19.66

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.07-0.12%
GSKGlaxoSmithKline-0.22-0.54%
SNYSanofi-0.77-1.90%
ABBVAbbVie-3.64-6.41%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateApril 29, 2016
EPS forecast (this quarter)$0.49
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Gladsaxe, Capital Region

Forecasts

Partner Offers